How to Get Entresto (sacubitril/valsartan) Covered by Cigna in Florida: Appeals, Forms, and Medical Necessity Requirements

Quick Answer: Getting Entresto Covered by Cigna in Florida

Fastest path to approval: Submit prior authorization with documented heart failure diagnosis (LVEF ≤40%), NYHA class, and prior ACE inhibitor/ARB failure or intolerance. If denied, file internal appeal within 180 days citing Florida step-therapy protections. Start today: Call Cigna at 1-800-882-4462 to request PA criteria and forms, or use your provider portal's electronic PA system.


Table of Contents

  1. Why Florida State Rules Matter
  2. Cigna's Entresto Coverage Requirements
  3. Prior Authorization Turnaround Standards
  4. Florida Step Therapy Protections
  5. Appeals Playbook for Cigna in Florida
  6. Medical Necessity Documentation
  7. External Review and State Complaints
  8. Costs and Patient Assistance
  9. FAQ: Common Questions

Why Florida State Rules Matter

Florida's insurance laws provide important protections when Cigna denies coverage for Entresto (sacubitril/valsartan). Under Florida Statute §627.42393, health insurers must follow specific step-therapy protocols and cannot impose arbitrary barriers.

Key Florida protections include:

  • Right to bypass step therapy if you completed it under a previous plan within 90 days
  • Mandatory protocol exemption process for medical necessity exceptions
  • Required timeframes for appeal decisions
  • Access to external review through independent organizations

These rules apply to commercial and ACA marketplace plans but not Medicare Advantage (which follows federal Medicare appeal rules) or self-funded employer plans that opt out.

Note: Different rules apply based on your plan type. Check your insurance card—if it says "Medicare" or mentions an employer's self-funded plan, federal rather than Florida state rules may govern your appeals.

Cigna's Entresto Coverage Requirements

Based on Cigna's formulary policies, Entresto typically requires prior authorization (PA) and step therapy on Florida plans. Here's what Cigna generally requires:

Coverage at a Glance

Requirement What It Means Documentation Needed
Heart Failure Diagnosis Chronic symptomatic HF with reduced ejection fraction ICD-10 code (I50.x), NYHA class II-IV
LVEF Documentation Left ventricular ejection fraction ≤40% Recent echocardiogram or cardiac imaging
Step Therapy Prior trial of ACE inhibitor or ARB Drug names, doses, duration, reason for discontinuation
Safety Requirements No concurrent ACE inhibitor use 36-hour washout period documented
Quantity Limits Standard dosing restrictions Clinical justification for higher doses if needed

Common Denial Reasons and Solutions

Denial Reason How to Address
"No HF diagnosis documented" Submit recent cardiology notes with NYHA class and LVEF
"Step therapy not met" Document ACE-I/ARB trial with specific failure/intolerance reasons
"Concurrent ACE inhibitor" Confirm 36-hour washout plan in appeal
"Quantity exceeds limits" Provide clinical rationale for dosing above standard limits

Prior Authorization Turnaround Standards

Cigna must follow federal timelines for PA decisions in Florida:

Standard Timelines

  • Pre-service requests: 30 days maximum
  • Post-service claims: 60 days maximum
  • Urgent/expedited requests: 72 hours maximum

How to Submit PA

  1. Electronic PA (fastest): Use your EHR's ePA module or CoverMyMeds portal
  2. Phone: Call Cigna provider line at 1-800-882-4462
  3. Fax/mail: Download Cigna's Entresto PA form (verify current form via provider portal)
Tip: Mark urgent requests as "EXPEDITED" if delay could seriously jeopardize the patient's health. Have the prescriber document this clinical urgency in writing.

Florida Step Therapy Protections

Florida law provides two main ways to bypass step therapy requirements:

1. Automatic Protection for Prior Plan Coverage

If you previously completed step therapy for Entresto under another health plan and have documentation showing payment within the last 90 days, Cigna cannot require you to repeat step therapy. This protection is explicit in Florida Statute §627.42393(2).

2. Medical Exception Criteria

You can request a step-therapy override if any of these apply:

  • Prior failure: ACE inhibitor or ARB was ineffective or caused intolerable side effects
  • Contraindications: History of angioedema, severe hyperkalemia, or other safety concerns
  • Current stability: Patient is stable on Entresto and switching would be medically inappropriate
  • FDA approval: Required step drug isn't FDA-approved for the patient's specific condition

Sample Appeal Language for Step Therapy

"Per Florida Statute §627.42393, I request a protocol exemption for Entresto. The patient has documented intolerance to lisinopril (persistent cough) and losartan (hypotension), making step therapy medically inappropriate. Current stability on guideline-directed therapy supports approval without delay."


Appeals Playbook for Cigna in Florida

Level 1: Internal Appeal

Timeline: File within 180 days of denial notice
Decision deadline: 30 days (standard) or 72 hours (urgent)
How to file: Cigna appeals portal or fax to number on denial letter

Required documents:

  • Copy of denial letter
  • Medical necessity letter from prescriber
  • Recent echo showing LVEF
  • Documentation of prior ACE-I/ARB trials
  • Current medication list

Level 2: External Review

When eligible: After Cigna upholds the denial in Level 1
Timeline: Request within 4 months of final denial
Process: Independent medical review through Florida-contracted organization
Cost: Free to patients

The external reviewer considers whether the denial was appropriate based on medical evidence and plan policies. In Medicare Advantage, about 82% of appealed denials are overturned.


Medical Necessity Documentation

Clinician Corner: Letter Checklist

When writing a medical necessity letter for Entresto, include:

Patient Information:

  • Specific heart failure diagnosis and ICD-10 code
  • NYHA functional class (II, III, or IV)
  • Most recent LVEF with date and imaging method

Treatment History:

  • Prior ACE inhibitor/ARB trials with drug names, doses, and duration
  • Specific reasons for discontinuation (efficacy failure, side effects, contraindications)
  • Current guideline-directed medical therapy

Clinical Rationale:

  • Reference to ACC/AHA Heart Failure Guidelines supporting ARNI therapy
  • Risk of hospitalization or cardiovascular death without optimal therapy
  • Why formulary alternatives are inappropriate

Safety Considerations:

  • Plan for ACE inhibitor washout period
  • Current labs (potassium, creatinine)
  • Monitoring plan
From our advocates: We've seen the strongest appeals include specific dates, lab values, and direct quotes from clinical guidelines. One composite case involved a patient whose appeal succeeded after the cardiologist cited the exact LVEF percentage and referenced the 21% reduction in cardiovascular death from the PARADIGM-HF trial.

External Review and State Complaints

Florida Department of Financial Services

If Cigna violates appeal timelines or procedures, file a complaint with Florida DFS Consumer Services. While they can't overturn medical decisions, they can:

  • Investigate procedural violations
  • Ensure proper appeal rights
  • Facilitate communication with insurers
  • Document patterns of inappropriate denials

How to file: Online complaint portal or call 1-877-MY-FL-CFO (1-877-693-5236)

When to Escalate

Contact Florida DFS if:

  • Cigna misses decision deadlines
  • Appeal procedures aren't followed properly
  • You're denied access to clinical criteria
  • Multiple inappropriate denials occur

Costs and Patient Assistance

Entresto Pricing and Support

  • Typical cost: Several hundred dollars monthly without coverage
  • Novartis copay card: May reduce out-of-pocket costs for eligible patients
  • Patient assistance programs: Available through Novartis Patient Assistance

Coverage Alternatives

If Entresto remains denied, discuss these FDA-approved alternatives with your cardiologist:

  • ACE inhibitors (lisinopril, enalapril)
  • ARBs (losartan, valsartan)
  • SGLT2 inhibitors for additional benefit
  • Optimization of beta-blockers and MRAs

Counterforce Health helps patients, clinicians, and pharmacies turn insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed rebuttals. The platform identifies the specific denial basis and drafts point-by-point responses aligned with each plan's own coverage rules, significantly improving approval rates for complex specialty medications like Entresto.


FAQ: Common Questions

Q: How long does Cigna prior authorization take in Florida?
A: Standard PA decisions take up to 30 days. Urgent requests must be decided within 72 hours. Use expedited review if delay poses serious health risks.

Q: What if Entresto is non-formulary on my Cigna plan?
A: Request a formulary exception through Cigna's appeals process. Provide medical necessity documentation showing why formulary alternatives are inappropriate.

Q: Can I request a peer-to-peer review?
A: Yes, ask your prescriber to request a peer-to-peer discussion with a Cigna medical director. This often resolves denials when clinical nuances need explanation.

Q: Does Florida step therapy protection apply to Medicare plans?
A: No, Florida Statute §627.42393 applies to commercial plans. Medicare Advantage follows federal Medicare appeal rules with different timelines and procedures.

Q: What happens if I'm stable on Entresto and switch insurance?
A: Under Florida law, if your previous plan covered Entresto within the last 90 days after completing step therapy, your new Cigna plan cannot reimpose step therapy requirements.

Q: How do I prove ACE inhibitor intolerance?
A: Document specific adverse effects (cough, angioedema, hypotension) with dates, dosages tried, and clinical notes. Lab values showing hyperkalemia or renal dysfunction also support intolerance claims.

Q: Can I appeal if my doctor isn't willing to write a letter?
A: Patients can file appeals independently, but prescriber support significantly improves success rates. Consider seeking a second opinion from a heart failure specialist if your current doctor won't advocate for appropriate therapy.


For additional support navigating complex insurance appeals, Counterforce Health specializes in turning denials into approvals through evidence-based appeal strategies tailored to each payer's specific requirements.


Sources & Further Reading


Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider about appropriate treatment options and work with qualified professionals for complex insurance appeals. Coverage policies and appeal procedures may vary by plan and change over time.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.